RIA
CTSO icon

Realta Investment Advisors’s Cytosorbents Corp CTSO Stock Holding History

Realta Investment Advisors’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-12,000
Closed -$40.4K – 834
2023
Q1 		$40.4K Buy
+12,000
New +$36K 0.01% 420

Other funds holding CTSO

SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
AC
Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JAMONY
Jacob Asset Management of New York Hermosa Beach, California $70.9M AUM 14.28% 1-Year Est. Return

Realta Investment Advisors's CTSO Position: Q2 2023 in Review

Realta Investment Advisors sold out of Cytosorbents Corp (CTSO) in Q2 2023, closing a stake of 12,000 shares — an estimated $40.4K sold.

Realta Investment Advisors first reported a position in CTSO in Q1 2023 and held it in 1 quarter. The position peaked at $40.4K in Q1 2023. 58 funds tracked by Wall St. Rank hold CTSO as of Q2 2023.

  • Realta Investment Advisors reported no remaining Cytosorbents Corp position as of Q2 2023 after selling out during the quarter.
  • Realta Investment Advisors sold 12,000 Cytosorbents Corp shares in Q2 2023, an estimated $40.4K.
  • Realta Investment Advisors first reported a position in Cytosorbents Corp in Q1 2023 and held it in 1 quarter.
  • Realta Investment Advisors's Cytosorbents Corp position peaked at $40.4K in Q1 2023.
  • 58 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q2 2023.

Based on Realta Investment Advisors's 13F filing for Q2 2023, filed 9 Aug 2023.